BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 37365541)

  • 1. Prediction of early improvement of major depressive disorder to antidepressant medication in adolescents with radiomics analysis after ComBat harmonization based on multiscale structural MRI.
    Ma H; Zhang D; Wang Y; Ding Y; Yang J; Li K
    BMC Psychiatry; 2023 Jun; 23(1):466. PubMed ID: 37365541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gray and white matter structural examination for diagnosis of major depressive disorder and subthreshold depression in adolescents and young adults: a preliminary radiomics analysis.
    Ma H; Zhang D; Sun D; Wang H; Yang J
    BMC Med Imaging; 2022 Sep; 22(1):164. PubMed ID: 36096776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Neuroimaging Biomarkers for Antidepressant Selection in Early Treatment of Depression.
    Xue L; Pei C; Wang X; Wang H; Tian S; Yao Z; Lu Q
    J Magn Reson Imaging; 2021 Aug; 54(2):551-559. PubMed ID: 33634921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.
    Castellano S; Ventimiglia A; Salomone S; Ventimiglia A; De Vivo S; Signorelli MS; Bellelli E; Santagati M; Cantarella RA; Fazio E; Aguglia E; Drago F; Di Nuovo S; Caraci F
    CNS Neurol Disord Drug Targets; 2016; 15(10):1290-1298. PubMed ID: 27712575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNRIs achieve faster antidepressant effects than SSRIs by elevating the concentrations of dopamine in the forebrain.
    Li J; Lu C; Gao Z; Feng Y; Luo H; Lu T; Sun X; Hu J; Luo Y
    Neuropharmacology; 2020 Oct; 177():108237. PubMed ID: 32710978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of remission among patients with a major depressive disorder based on the resting-state functional connectivity of emotion regulation networks.
    Wu H; Liu R; Zhou J; Feng L; Wang Y; Chen X; Zhang Z; Cui J; Zhou Y; Wang G
    Transl Psychiatry; 2022 Sep; 12(1):391. PubMed ID: 36115833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trajectory and magnitude of response in adults with anxiety disorders: a Bayesian hierarchical modeling meta-analysis of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and benzodiazepines.
    Mendez EM; Mills JA; Suresh V; Stimpfl JN; Strawn JR
    CNS Spectr; 2024 Jun; 29(3):187-196. PubMed ID: 38523533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurometabolite changes in response to antidepressant medication: A systematic review of
    Boucherie DE; Reneman L; Ruhé HG; Schrantee A
    Neuroimage Clin; 2023; 40():103517. PubMed ID: 37812859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ensemble Learning for Early-Response Prediction of Antidepressant Treatment in Major Depressive Disorder.
    Pei C; Sun Y; Zhu J; Wang X; Zhang Y; Zhang S; Yao Z; Lu Q
    J Magn Reson Imaging; 2020 Jul; 52(1):161-171. PubMed ID: 31859419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic Resonance Imaging Measures of Brain Structure to Predict Antidepressant Treatment Outcome in Major Depressive Disorder.
    Korgaonkar MS; Rekshan W; Gordon E; Rush AJ; Williams LM; Blasey C; Grieve SM
    EBioMedicine; 2015 Jan; 2(1):37-45. PubMed ID: 26137532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared and unique imaging-derived endo-phenotypes of two typical antidepressant-applicative depressive patients.
    Xue L; Shao J; Wang H; Wang X; Zhu R; Yao Z; Lu Q
    Eur Radiol; 2023 Jan; 33(1):645-655. PubMed ID: 35980436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of SSRIs and SNRIs in major depressive disorder: a meta-analysis of head-to-head randomized clinical trials.
    Machado M; Einarson TR
    J Clin Pharm Ther; 2010 Apr; 35(2):177-88. PubMed ID: 20456736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of nonremission to antidepressant therapy using diffusion tensor imaging.
    Grieve SM; Korgaonkar MS; Gordon E; Williams LM; Rush AJ
    J Clin Psychiatry; 2016 Apr; 77(4):e436-43. PubMed ID: 27137427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.
    Jakubovski E; Johnson JA; Nasir M; Müller-Vahl K; Bloch MH
    Depress Anxiety; 2019 Mar; 36(3):198-212. PubMed ID: 30479005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute trajectories of neural activation predict remission to pharmacotherapy in late-life depression.
    Karim HT; Wang M; Andreescu C; Tudorascu D; Butters MA; Karp JF; Reynolds CF; Aizenstein HJ
    Neuroimage Clin; 2018; 19():831-839. PubMed ID: 30013927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma grading prediction using multiparametric magnetic resonance imaging-based radiomics combined with proton magnetic resonance spectroscopy and diffusion tensor imaging.
    Lin K; Cidan W; Qi Y; Wang X
    Med Phys; 2022 Jul; 49(7):4419-4429. PubMed ID: 35366379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postpartum Bleeding in Pregnant Women Receiving SSRIs/SNRIs: New Insights From a Descriptive Observational Study and an Analysis of Data from the FAERS Database.
    Perrotta C; Giordano F; Colombo A; Carnovale C; Castiglioni M; Di Bernardo I; Giorgetti F; Pileri P; Clementi E; Viganò C
    Clin Ther; 2019 Sep; 41(9):1755-1766. PubMed ID: 31371035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder.
    Bartova L; Fugger G; Dold M; Kautzky A; Fanelli G; Zanardi R; Albani D; Weidenauer A; Rujescu D; Souery D; Mendlewicz J; Montgomery S; Zohar J; Fabbri C; Serretti A; Kasper S
    J Affect Disord; 2023 Jul; 332():105-114. PubMed ID: 36958488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.